{"id":"https://openalex.org/W2117761119","doi":"https://doi.org/10.1586/14737167.6.3.325","title":"Strategies to improve adherence with medications in chronic, \u2018silent\u2019 diseases representing high cardiovascular risk","display_name":"Strategies to improve adherence with medications in chronic, \u2018silent\u2019 diseases representing high cardiovascular risk","publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W2117761119","doi":"https://doi.org/10.1586/14737167.6.3.325","mag":"2117761119","pmid":"https://pubmed.ncbi.nlm.nih.gov/20528525"},"language":"en","primary_location":{"id":"doi:10.1586/14737167.6.3.325","doi":"https://doi.org/10.1586/14737167.6.3.325","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737167.6.3.325","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076341878","display_name":"Anju Parthan","orcid":"https://orcid.org/0000-0002-2357-9479","observed_orcids":["https://orcid.org/0000-0002-2357-9479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anju Parthan","raw_affiliation_strings":["Mapi Values, 15 Court Square, Suite 620, Boston, 02108, USA. anju.parthan@mapivalues.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mapi Values, 15 Court Square, Suite 620, Boston, 02108, USA. anju.parthan@mapivalues.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040715760","display_name":"G Vincze","orcid":"https://orcid.org/0000-0003-1421-7457","observed_orcids":["https://orcid.org/0000-0003-1421-7457"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"G\u00e1bor Vincze","raw_affiliation_strings":["Novartis Pharma AG, Pharma Affairs, CH-4002 Basel, Switzerland. gabor.vincze@novartis.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Pharma Affairs, CH-4002 Basel, Switzerland. gabor.vincze@novartis.com","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022854257","display_name":"Donald Edward Morisky","orcid":"https://orcid.org/0000-0003-1338-2231","observed_orcids":["https://orcid.org/0000-0003-1338-2231"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald E Morisky","raw_affiliation_strings":["UCLA School of Public Health, 650 Charles E. Young Drive South, Box 951772 26\u2013070 CHS, Los Angeles, CA 90095\u20131772, USA. dmorisky@ucla.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA School of Public Health, 650 Charles E. Young Drive South, Box 951772 26\u2013070 CHS, Los Angeles, CA 90095\u20131772, USA. dmorisky@ucla.edu","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108758819","display_name":"Zeba M. Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zeba M Khan","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936\u20131080, USA. zeba.khan@novartis.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936\u20131080, USA. zeba.khan@novartis.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2788,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.67376929,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"6","issue":"3","first_page":"325","last_page":"336"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.996999979019165},{"id":"https://openalex.org/keywords/chronic-disease","display_name":"chronic disease","score":0.44200000166893005},{"id":"https://openalex.org/keywords/silent-disease","display_name":"silent disease","score":0.703000009059906},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9620000123977661},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.9559999704360962},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":1.0},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":1.0},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7419999837875366},{"id":"https://openalex.org/keywords/blood-pressure-control","display_name":"blood pressure control","score":0.8410000205039978},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9559999704360962},{"id":"https://openalex.org/keywords/barriers-to-adherence","display_name":"barriers to adherence","score":0.6790000200271606},{"id":"https://openalex.org/keywords/self-management-plans","display_name":"self-management plans","score":0.8989999890327454},{"id":"https://openalex.org/keywords/adherence-interventions","display_name":"adherence interventions","score":0.6759999990463257},{"id":"https://openalex.org/keywords/patient-registry","display_name":"patient registry","score":0.8619999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7483288049697876},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7478643655776978},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.6775956749916077},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.6166499853134155},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6149123907089233},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6123186945915222},{"id":"https://openalex.org/C2780665704","wikidata":"https://www.wikidata.org/wiki/Q959298","display_name":"Intervention (counseling)","level":2,"score":0.5260332226753235},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5090500712394714},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.4752899408340454},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.45871666073799133},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.360512375831604},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.16903099417686462},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15912076830863953},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1586/14737167.6.3.325","doi":"https://doi.org/10.1586/14737167.6.3.325","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14737167.6.3.325","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},{"id":"pmid:20528525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20528525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of pharmacoeconomics & outcomes research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W10868823","https://openalex.org/W45538457","https://openalex.org/W101424835","https://openalex.org/W146818093","https://openalex.org/W174129661","https://openalex.org/W202756716","https://openalex.org/W1421647220","https://openalex.org/W1509609699","https://openalex.org/W1579286767","https://openalex.org/W1964267627","https://openalex.org/W1964554838","https://openalex.org/W1972344259","https://openalex.org/W1972362505","https://openalex.org/W1979189109","https://openalex.org/W1981747202","https://openalex.org/W1984207232","https://openalex.org/W1989252935","https://openalex.org/W1993187958","https://openalex.org/W1994578999","https://openalex.org/W1997584320","https://openalex.org/W2005233914","https://openalex.org/W2011990461","https://openalex.org/W2031213792","https://openalex.org/W2031450812","https://openalex.org/W2031756259","https://openalex.org/W2035081010","https://openalex.org/W2040485944","https://openalex.org/W2042394770","https://openalex.org/W2042694950","https://openalex.org/W2042873619","https://openalex.org/W2046575388","https://openalex.org/W2048412252","https://openalex.org/W2053538299","https://openalex.org/W2056781428","https://openalex.org/W2057112394","https://openalex.org/W2062717732","https://openalex.org/W2063001046","https://openalex.org/W2066005509","https://openalex.org/W2066929611","https://openalex.org/W2076822779","https://openalex.org/W2077210128","https://openalex.org/W2078467241","https://openalex.org/W2079134517","https://openalex.org/W2079385393","https://openalex.org/W2085066808","https://openalex.org/W2100447241","https://openalex.org/W2100507660","https://openalex.org/W2105950556","https://openalex.org/W2108942104","https://openalex.org/W2110695159","https://openalex.org/W2114878544","https://openalex.org/W2123946565","https://openalex.org/W2124129401","https://openalex.org/W2136225651","https://openalex.org/W2139584372","https://openalex.org/W2146540041","https://openalex.org/W2151512706","https://openalex.org/W2155867833","https://openalex.org/W2164733897","https://openalex.org/W2165903684","https://openalex.org/W2182142554","https://openalex.org/W2345422376","https://openalex.org/W2993199405","https://openalex.org/W3011008835"],"related_works":["https://openalex.org/W2410806947","https://openalex.org/W7108605014","https://openalex.org/W7134256838","https://openalex.org/W4390571189","https://openalex.org/W2274341644","https://openalex.org/W4390647390","https://openalex.org/W4416232826","https://openalex.org/W2493394708","https://openalex.org/W2095215447","https://openalex.org/W6902180640"],"abstract_inverted_index":{"Given":[0],"the":[1,40,90,183],"burden":[2],"of":[3,67],"illness":[4],"related":[5],"to":[6,15,29,78,106,113,117,122,126,131,136,181],"diabetes,":[7],"hypertension":[8],"and":[9,22,37,99,130,175],"dyslipidemia,":[10],"it":[11],"is":[12,43,60,80],"very":[13],"important":[14],"achieve":[16],"glycemic":[17],"control,":[18],"optimal":[19],"blood":[20],"pressure":[21],"low-density":[23],"lipoprotein":[24],"cholesterol":[25],"(LDL-C)":[26],"in":[27,47,54,179],"order":[28,180],"avoid":[30],"severe":[31],"long-term":[32],"complications.":[33],"Patients'":[34],"adherence":[35,124,177],"with,":[36],"persistence":[38],"to,":[39],"treatment":[41],"regimen":[42],"a":[44,64,81],"critical":[45],"factor":[46],"achieving":[48],"this":[49],"goal.":[50],"Medication":[51],"taking":[52],"behavior":[53],"these":[55],"chronic,":[56],"nonsymptomatic":[57],"('silent')":[58],"diseases":[59],"generally":[61],"low,":[62],"although":[63],"wide":[65],"range":[66],"results":[68],"have":[69],"been":[70],"reported.":[71],"The":[72,119],"literature":[73],"has":[74],"shown":[75],"that":[76,150],"nonadherence":[77],"medications":[79],"multidimensional":[82],"phenomenon;":[83],"relating":[84],"factors":[85],"can":[86],"be":[87,114,169],"grouped":[88],"into":[89],"following":[91],"categories:":[92],"health":[93],"system":[94],"related,":[95],"social/economic,":[96],"condition-related,":[97],"therapy-related":[98],"patient-related":[100],"factors.":[101],"Although":[102],"several":[103],"interventions":[104],"exist":[105],"improve":[107,123],"patients'":[108],"medication-taking":[109],"behavior,":[110],"none":[111],"appear":[112],"clearly":[115],"superior":[116],"others.":[118],"key":[120],"steps":[121],"are":[125],"identify":[127],"individual":[128],"barriers":[129],"develop":[132],"patient-specific":[133],"self-management":[134],"plans":[135],"overcome":[137],"them":[138],"(called":[139],"'patient-centric'":[140],"approach).":[141],"When":[142],"developing":[143],"intervention":[144],"strategies":[145],"one":[146],"should":[147],"always":[148],"remember":[149],"'one":[151],"size":[152],"does":[153],"not":[154,160],"fit":[155],"all'.":[156],"Well":[157],"designed":[158],"(but":[159],"randomized),":[161],"observational":[162],"studies":[163],"(for":[164],"example,":[165],"patient":[166],"registries)":[167],"may":[168],"required":[170],"with":[171],"sufficient":[172],"follow-up":[173],"periods":[174],"multiple":[176],"measurements":[178],"advance":[182],"field.":[184]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}